Muscling in on salbutamol

[1]  N. Rothwell,et al.  Anabolic effects of clenbuterol on skeletal muscle are mediated by beta 2-adrenoceptor activation. , 1992, The American journal of physiology.

[2]  A. Morton,et al.  IS SALBUTAMOL ERGOGENIC?: THE EFFECTS OF SALBUTAMOL ON PHYSICAL PERFORMANCE IN HIGH-PERFORMANCE NONASTHMATIC ATHLETES , 1992 .

[3]  S. O'keefe,et al.  Impact of Malnutrition and Its Therapy on Liver Transplantation , 1991, Seminars in liver disease.

[4]  D. Morgan,et al.  Clinical Pharmacokinetics of β-Agonists , 1990 .

[5]  Y. Yang,et al.  Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue. , 1989, The Biochemical journal.

[6]  J. A. Page,et al.  Metabolic studies of salbutamol-3H: A new bronchodilator, in rat, rabbit, dog and man , 1971 .

[7]  W. T. Simpson,et al.  Human pharmacological and clinical studies on salbutamol: a specific beta-adrenergic bronchodilator. , 1969, British journal of diseases of the chest.

[8]  J. Young,et al.  Heart transplant nutrition programs: a national survey. , 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[9]  S. Walker,et al.  The metabolism of salbutamol in man. , 1973, Xenobiotica; the fate of foreign compounds in biological systems.